Jifang Sheng Selected Research

Hepatitis B

3/2022	Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?
1/2020	Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.
9/2019	A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a.
1/2019	Prognostic utility of novel biomarkers in acute-on-chronic liver failure (ACLF) associated with hepatitis B: A multicenter prospective study.
2/2018	Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.
2/2016	Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jifang Sheng Research Topics

Disease

19	COVID-19 01/2022 - 01/2020
16	Chronic Hepatitis B 03/2022 - 04/2014
13	Infections 03/2022 - 01/2007
6	Hepatitis B 03/2022 - 02/2016
4	Fever (Fevers) 01/2022 - 06/2013
4	Inflammation (Inflammations) 06/2021 - 01/2007
4	Pneumonia (Pneumonitis) 01/2021 - 06/2013
4	Acute-On-Chronic Liver Failure 01/2021 - 01/2013
3	Neoplasms (Cancer) 01/2022 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
3	End Stage Liver Disease 01/2021 - 01/2018
3	Cytokine Release Syndrome 01/2021 - 01/2020
3	Hypertension (High Blood Pressure) 12/2020 - 01/2020
3	Critical Illness (Critically Ill) 12/2020 - 01/2020
3	Disease Progression 01/2020 - 06/2013
3	Coinfection 01/2020 - 06/2013
2	Hepatic Encephalopathy 12/2021 - 01/2021
2	Nausea 01/2021 - 05/2020
2	Fibrosis (Cirrhosis) 01/2021 - 01/2020
2	Bacterial Infections (Bacterial Infection) 12/2020 - 01/2020
2	Dyspnea (Shortness of Breath) 05/2020 - 01/2020
2	Shock 01/2020 - 02/2016
2	Influenza in Birds (Avian Flu) 01/2020 - 02/2016
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2010
2	Ascites 03/2018 - 01/2018
2	Meningitis 01/2011 - 04/2010
1	Hepatitis 03/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2022
1	Leukemia 06/2021
1	Ischemic Stroke 01/2021
1	Rhinorrhea 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Diarrhea 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Human Influenza (Influenza) 01/2021

Drug/Important Bio-Agent (IBA)

13	Hepatitis B e AntigensIBA 01/2020 - 04/2014
6	Viral RNAIBA 01/2022 - 01/2020
6	CytokinesIBA 06/2021 - 06/2013
6	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2015
5	Pharmaceutical PreparationsIBA 03/2022 - 04/2010
4	Alanine Transaminase (SGPT)IBA 01/2021 - 04/2015
4	AlbuminsIBA 01/2021 - 01/2020
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 10/2016
3	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2021 - 05/2020
3	C-Reactive ProteinIBA 02/2021 - 02/2016
3	Nucleic AcidsIBA 01/2021 - 07/2020
3	ChemokinesIBA 01/2021 - 06/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 01/2020
3	AntigensIBA 01/2020 - 02/2018
3	entecavir FDA Link 01/2020 - 10/2014
3	InterferonsIBA 09/2019 - 12/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2019 - 06/2013
2	Tenofovir (Viread)FDA Link 03/2022 - 05/2019
2	Creatine Kinase (Creatine Phosphokinase)IBA 03/2022 - 05/2020
2	BilirubinIBA 12/2021 - 05/2020
2	Interleukin-18 (Interleukin 18)IBA 06/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 12/2020
2	AcidsIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 12/2020 - 12/2020
2	SodiumIBA 05/2020 - 03/2018
2	Telbivudine FDA Link 01/2020 - 04/2014
2	ProcalcitoninIBA 01/2020 - 02/2016
2	Ritonavir (Norvir)FDA Link 01/2020 - 09/2019
2	VaccinesIBA 01/2020 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2020
2	peginterferon alfa-2b (Pegintron)FDA Link 10/2016 - 12/2014
2	Antimicrobial Cationic PeptidesIBA 01/2011 - 04/2010
1	nasIBA 03/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Biological ProductsIBA 01/2022
1	CarbohydratesIBA 01/2022
1	cobicistat mixture with darunavirIBA 01/2022
1	AmphiregulinIBA 06/2021
1	EpiregulinIBA 06/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	1,5-anhydroglucitolIBA 01/2021
1	palmitoleic acidIBA 01/2021
1	phosphoric acid (orthophosphoric acid)FDA Link 01/2021
1	2-hydroxybutyric acidIBA 01/2021
1	sitafloxacinIBA 01/2021
1	2-palmitoylglycerolIBA 01/2021
1	4-deoxythreonic acidIBA 01/2021
1	Moxifloxacin (Avelox)FDA Link 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	CholesterolIBA 01/2021
1	ElementsIBA 01/2021
1	FructoseIBA 01/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 04/2010
5	Artificial Liver (Bioartificial Liver) 12/2020 - 01/2013
4	Artificial Respiration (Mechanical Ventilation) 01/2020 - 02/2016
2	Aftercare (After-Treatment) 03/2022 - 12/2014
2	Duration of Therapy 05/2020 - 12/2014
2	Extracorporeal Membrane Oxygenation 01/2020 - 02/2016
2	Liver Transplantation 03/2018 - 01/2013
2	Length of Stay 01/2018 - 11/2015
1	Ketogenic Diet 01/2022